Pharmacy World & Science

, Volume 30, Issue 5, pp 617–619 | Cite as

Social pharmacy strengthening clinical pharmacy: why pharmaceutical policy research is needed in Pakistan?

  • Zaheer-Ud-Din BabarEmail author
  • Shazia Jamshed


Pakistan has a population of more than 160 million and is the sixth most populous country in the world. Drugs are the most common form of treatment modality; however, inappropriate use of medicines is a crucial issue in the country. In Pakistan, recently there is a surge of number of pharmacy schools, the pharmacy degree (B. Pharm) has been changed to Pharm D and there is a lot of rhetoric about “clinical pharmacy”. However, whether this change has brought any significant improvement in drug use situation; it is still a moot question for academics and policy makers. Authors feel that before embarking upon on clinical pharmacy at an institutional level, it is important that basic pharmacy system should be in place. Thus, a strong culture in social pharmacy or pharmaceutical policy research will not only be helpful to establish clinical pharmacy practice, but it would also be supportive enough to provide manpower to the country’s proposed drug regulatory authority.


Clinical pharmacy Pakistan Pharmaceutical policy research Pharmacy education Social pharmacy 



We thank Medicines Pakistan International for being a useful forum for constructive discussions.



Conflicts of interest



  1. 1.
    WHO Pakistan Country Profile. Accessed 28 May 2008.
  2. 2.
    Pakistan, the World Fact Book. Accessed 29 May 2008.
  3. 3.
    The World Medicines Situation. World Health Organization. 2004. WHO/EDM/PAR/2004.5. Accessed 22 May 2008.
  4. 4.
    Laing R. Health and pharmacy systems in developing countries. Paper presented Hosbjor Norway. 2001. Accessed 9 April 2001.
  5. 5.
    About social pharmacy. Faculty of Pharmacy, Universitetet I Oslo.
  6. 6.
    Babar ZU. Pharmacy education and practice in Pakistan. Am J Pharm Educ. 2005;69(05):2–3.Google Scholar
  7. 7.
    Clinical Pharmacy. European Society of Clinical Pharmacy. Accessed 20 May 2008.
  8. 8.
    Babar ZU. Pakistan’s National University of Pharmaceutical Sciences. Am J Pharm Educ. 2006;70(5):123.Google Scholar
  9. 9.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMedGoogle Scholar
  10. 10.
    Weidenmayer K, Summers RS, Mackie CA, Gous AGS, Everard M, Tromp D. Developing pharmacy practice: a focus on patient care. Working draft for the filed testing and revision, World Health Organization (WHO) and International Pharmaceutical Federation 2006. WHO/PSM/PAR/2006.5.Google Scholar
  11. 11.
    Desselle SP. The birth of research in social & administrative pharmacy: a sincere welcome to subscribers, readers, and authors. Res Social Adm Pharm. 2005;1:1–4. doi: 10.1016/j.sapharm.2004.12.001.PubMedGoogle Scholar
  12. 12.
    Department of Social Pharmacy Faculty of Pharmacy. University of Kuopio. Accessed 19 May 2008.
  13. 13.
    The Network for Consumer Protection. Islamabad, Pakistan. Accessed 6 April 2008.
  14. 14.
    Nishtar S. The Gateway Paper: the health systems in Pakistan—a way forward. Accessed 27 May 2008.
  15. 15.
    Babar ZU. Rationale Behind Drug Pricing. 2008. Dawn 26 Feb.

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  1. 1.School of Pharmacy, Faculty of Medical & Health SciencesThe University of AucklandAucklandNew Zealand
  2. 2.Discipline of Social & Administrative Pharmacy, School of Pharmaceutical SciencesUniversiti Sains MalaysiaPenangMalaysia

Personalised recommendations